Extract from report on largest and most recent study on HIFU https://www.sciencedaily.com/releases/2018/07/180705114140.htm
'The scientists also tracked the number of patients who needed further treatment following HIFU, (such as surgery or radiotherapy), to treat any cancer cells that had returned. They found 10 per cent of patients needed further treatment by five years, which is comparable to number of patients needing further treatment after surgery or radiotherapy (5-15 per cent)'
We will have to see what the 10 year analysis shows with the Sonarblate which now seems to be preferred in the UK to the Ablertherm referred to in analysis in earlier studies. Also, in these other studies not all candidates may have been suitable candidates for HIFU. Furthermore, there were more cases where HIFU was directed at the whole gland whereas now it is more used only for 'significant' tumours which increases its effectiveness.
A crucial aspect is that men are carefully selected for HIFU because the cancer can become so difficult to deal with through location, volume or intensity that more radical treatment becomes more appropriate. But for suitable men, the overall possibility of a milder treatment that can be repeated or in need followed by more radical treatment, coupled with the less severe side effects of HIFU could make it a preferable option.
Edited by member 11 Jan 2021 at 06:33
| Reason: to highlight link